2 studies found for:    16258083 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 Therapies
Condition: Metastatic Breast Cancer
Interventions: Drug: Lapatinib;   Drug: Trastuzumab
2 Active, not recruiting Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
Condition: Breast Cancer
Interventions: Biological: herceptin;   Drug: adriamycin;   Drug: cyclophosphamide;   Drug: taxol

Indicates status has not been verified in more than two years